Medprin announced that the concert party agreement between controlling shareholder Yuan Yuyu and shareholder Xu Tao expired on 27 July 2026, and the two parties will no longer aggregate their shareholdings. After this change, Yuan Yuyu still directly holds 11.0813 million shares, representing a 16.53% stake, and remains the company's actual controller; control of the company has not changed. Notably, the company has received approval from the China Securities Regulatory Commission to issue shares to entities controlled by or associated with Yuan Yuyu to acquire 100% equity in Yijie Medical and to raise matching funds. If completed, the total equity Yuan Yuyu controls in the company will increase accordingly. Currently, 6.02 million of the shares held by Yuan Yuyu are pledged.
Medprin Regenerative Medical Technologies Co. Ltd.Concert party agreement expiration does not change control, but share issuance to acquire Yijie Medical is pending; net effect unclear.
Medprin's planned acquisition of Yijie Medical via share issuance implies a positive valuation event for Yijie Medical.